Expert Review of Precision Medicine and Drug Development
Taylor & Francis · United Kingdom
Metrics
- Impact factor
- 1.5+0.3 Clarivate JCR
- WoS quartile
- Q4 Clarivate JCR, best category
- SJR
- 0.25Q3 SCImago
- h-index
- 19
- CAS tier
- Tier 4 Chinese Academy of Sciences
- Citations per paper
- 1.89 last 2 years
- Articles per year
- 28
- Self-citation
- 0%
- Fee (APC), est.
- $2,622 estimated, check the journal
About this journal
- ISSN
- 2380-8993 (print)
- Publisher
- Taylor & Francis
- Country
- United Kingdom · Western Europe
- Indexed in
- ESCI
- Access
- Hybrid · 20% gold OA
- Original research
- 50%
- Subject areas
- Biochemistry, Genetics and Molecular Biology, Pharmacology, Toxicology and Pharmaceutics
- Categories
- Pharmacology & Pharmacy
- Common topics
- Medicine, Biology, Genetics, Internal medicine, Pathology
Similar journals
- Q4WoS
FEMS Microbiology Letters
Impact factor 2h-index 134SJR 0.60 - Q4WoS
Lipids
Impact factor 1.6h-index 114SJR 0.43 - Q4WoS
Genes to Cells
Impact factor 1.4h-index 109SJR 0.55 - Q4WoS
Molecular and Biochemical Parasitology
Impact factor 1.4h-index 103SJR 0.40 - Q4WoS
Microbial Physiology
Impact factor 1.9h-index 92SJR 0.49 - Q4WoS
Oncology
Impact factor 1.9h-index 92SJR 0.60
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals